Abstract
patients. Recent data suggest that the development of metastatic disease is uncommon during active surveillance of SRMs over 3 to 5 years. Here we evaluate competing causes of non-cancer and cancer based death and compare these to death rates from RCC in age matched patients. METHODS: Mortality and survival rates in the United States were determined from the National Vital Statistics Reports. Patients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
